Authors: MCCLAY EF MCCLAY MET JONES JA WINSKI PJ CHRISTEN RD HOWELL SB HALL PD

Citation: Ef. Mcclay et al., A PHASE-I AND PHARMACOKINETIC STUDY OF HIGH-DOSE TAMOXIFEN AND WEEKLYCISPLATIN IN PATIENTS WITH METASTATIC MELANOMA, Cancer, 79(5), 1997, pp. 1037-1043

Authors: MCCLAY EF MCCLAY MET

Citation: Ef. Mcclay et Met. Mcclay, SYSTEMIC CHEMOTHERAPY FOR THE TREATMENT OF METASTATIC MELANOMA, Seminars in oncology, 23(6), 1996, pp. 744-753

Authors: MCCLAY EF MCCLAY MET

Citation: Ef. Mcclay et Met. Mcclay, TAMOXIFEN AND CHEMOTHERAPY IN THE TREATMENT OF METASTATIC MELANOMA - ARE THERE OTHER POSSIBLE MECHANISMS EXPLAINING THEIR POTENTIATION - REPLY, Journal of clinical oncology, 12(9), 1994, pp. 1996-1996

Authors: MCCLAY EF MCCLAY MET

Citation: Ef. Mcclay et Met. Mcclay, TAMOXIFEN - IS IT USEFUL IN THE TREATMENT OF PATIENTS WITH METASTATICMELANOMA, Journal of clinical oncology, 12(3), 1994, pp. 617-626

Authors: MCCLAY EF MCCLAY MET ALBRIGHT KD JONES JA CHRISTEN RD ALCARAZ J HOWELL SB

Citation: Ef. Mcclay et al., TAMOXIFEN MODULATION OF CISPLATIN RESISTANCE IN PATIENTS WITH METASTATIC MELANOMA - A BIOLOGICALLY IMPORTANT OBSERVATION, Cancer, 72(6), 1993, pp. 1914-1918